Please assess the completion status of the following clinical trial:

Trial Title: Interaction of Apelin and Angiotensin in the Human Forearm Circulation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \> 18 years old~Exclusion Criteria:~* Lack of informed consent~* Age \< 18 years,~* Current involvement in other research studies,~* Systolic blood pressure \>190 mmHg or \<100 mmHg~* Malignant arrhythmias~* Renal or hepatic failure~* Haemodynamically significant aortic stenosis~* Severe or significant co morbidity~* Women of childbearing potential.~* Any regular medication~* Previous history of any cardiovascular disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Angiotensin II infusion (Type: EXPERIMENTAL): Using forearm venous occlusion plethysmography angiotensin II will be infused to cause reduction in forearm blood flow. Infusion of apelin and sodium nitroprusside will given and vasodilatation will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.
- Noradrenaline (Type: ACTIVE_COMPARATOR): Using forearm venous occlusion plethysmography noradrenaline will be infused to cause reduction in forearm blood flow. Infusion of apelin and sodium nitroprusside will given and vasodilatation will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.

Based on this trial design, predict the completion outcome and termination type (if applicable).